Fevertree Drinks PLC (FEVR) · 2026-09-10
Fevertree's H1 FY26 adjusted revenue rose 7% and adjusted EBITDA increased 9% to £20.1 million, but cash fell to £68.0 million from £130.0 million, primarily due to buybacks. FY26 expectations remain in line with market expectations.
Fevertree Drinks (FEVR) · 2026-07-01
Fevertree Drinks has commenced a GBP30m extension to its share buyback programme. This increases the total maximum consideration to GBP60m, with the extension scheduled to run until 31 December 2026.
Fever-Tree Drinks plc (FEVR) · 2026-06-09
Fever-Tree Drinks said it remains confident of achieving full-year market expectations for adjusted revenue and EBITDA. The company announced a further £30m extension to its on-going share buyback programme, with £18.9m returned from the ongoing £30m tranche as of 5 June 2026. Progress in the US partnership and strong momentum in Australia supported confidence, alongside extended energy hedging through 2028.